Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has launched its HealthTab(TM) platform in various Shoppers Drug Mart(R) pharmacies located throughout British Columbia. This move marks the first time the company’s diabetes screening program has been available in Western Canada. Avricore signed a master agreement with Shoppers Drug Mart Inc. earlier this year. That agreement involved a pilot program that provided patients with access to point-of-care blood screening and health-data management for potential risks for developing diabetes and cardiovascular conditions. Those services were offered through AVCRF’s HealthTab-integrated Afinion 2(TM) analyzers by Abbott Rapid Diagnostics. Based on the positive feedback from both patients and pharmacists, Shoppers Drug Mart began looking for ways that more patients could benefit from the service. This new agreement is one of those ways. “The launch in Shoppers Drug Mart pharmacies in Ontario has been very successful, and we are very happy to see the program lay the groundwork for expansion,” said Avricore Health CEO Hector Bremner in the press release. “Having a real-time patient observation program reporting seamlessly across 3000kms is very unique, and we are very proud to deliver this innovation.”
To view the full press release, visit https://ibn.fm/0m00l
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab, a wholly owned subsidiary, the company’s mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, please visit www.AvricoreHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
InvestorWire is part of the InvestorBrandNetwork.